bioRxiv Science⌕ Search

Biology subjects

Hwang, I.-J.

Publications and source records attributed to Hwang, I.-J..

2 recordsLinked to original sources

Chemically Engineered Carbon Nanotubes Map Class-Selective Metabolite Enrichment from Human Plasma

The spontaneous adsorption of biomolecules onto nanoparticle surfaces has been extensively characterized at the protein level, but the metabolite corona remains poorly defined while being physicochemically and biologically distinctive. Herein, we report the first class-level mapping of metabolite corona composition across 25 chemically modified carbon nanotubes in human plasma using untargeted liquid chromatography-mass spectrometry. Complementary analytical conditions detected approximately 9,000 metabolite features, of which over 5,000 yielded valid corona-versus-plasma enrichment measurements. Machine learning classifiers extended metabolite class annotations from 10-45% to the full detected set, enabling systematic analysis of class-level enrichment patterns. We find that polymer wrapping dominates corona composition, with DNA wrapping selectively enriching nonpolar lipids and PEG wrapping favoring polar metabolites. Within each polymer background, covalent quantum well defects further modulate class-level enrichment in a structure- and chemistry-dependent manner. Carboxyl aryl defects broadly enhance amphiphilic lipid recruitment, while trifluoro aryl defects suppress single-chain amphiphilic species but attenuate depletion of double-chain phospholipids. Our findings demonstrate that engineered nanotubes can serve as chemically tunable, selective scaffolds for metabolite enrichment, potentially enhancing the capability of nanotube-based platforms to recruit and detect structurally diverse, low-abundance small molecules in complex biofluids.

biochemistry↗

Engineering Carbon Nanotube Quantum Well Defects with Recognition Tripeptides for Optical Detection of Extracellular Vesicles in Plasma

Extracellular vesicles (EVs) carry molecular signatures of their originating cells and have thus emerged as promising biomarkers. However, their clinical utility remains limited due to their low abundance and the modest sensitivity of current EV detection methods in complex biological environments. Here, we present a quantum well defect functionalized carbon nanotube sensor coupled with integrin-recognition RGD tripeptide for EV detection in human plasma. Leveraging the abundance of integrins on EV surfaces, we targeted 5{beta}1, V{beta}1, and V{beta}3 subtypes. The nanosensor exhibited robust hypsochromic shifts in defect emission upon integrin binding, achieving sub-picomolar detection limits for integrin subunits and quantifying EVs at concentrations as low as 104 EVs{middle dot}mL-1 for glioblastoma, ovarian cancer, and fibroblast cell-derived EV types. Molecular dynamics simulation indicated that integrin docking at the RGD-coupled quantum defect can substantially reshape the interfacial environments of the quantum defects, explaining the high sensitivity in EV detection in complex biological media. Finally, transmembrane protein analysis validated the expression of surface integrins across the tested EV types. The modular nanosensor construct can be targeted to detect disease-associated EV subpopulations, advancing EV-based diagnostics.

biochemistry↗